Innocrin Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Innocrin Pharmaceuticals General Information

Description

Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating castration-resistant prostate cancer and are used in other hormonally-driven conditions such as endometriosis or congenital adrenal hyperplasia, thereby enabling hospitals to treat even non-oncologic syndromes caused due to excessive androgen production.

Contact Information

Website
www.innocrinpharma.org
Formerly Known As
Hephestics, Viamet Pharmaceuticals
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4220 Appex Highway 55
  • Suite 330
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Medical Supplies
Drug Delivery
Therapeutic Devices
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4220 Appex Highway 55
  • Suite 330
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innocrin Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Oct-2019 Completed Out of Business
4. Later Stage VC 13-Jul-2017 Completed Generating Revenue
3. Grant 31-Dec-2016 Completed Generating Revenue
2. Later Stage VC 20-Apr-2015 $28.1M $28.1M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Innocrin Pharmaceuticals’s complete valuation and funding history, request access »

Innocrin Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oral inhibitors designed to treat breast and prostate cancer. The company's inhibitors help in treating cas
Drug Discovery
Durham, NC
10 As of 2016

Groningen, Netherlands
 

New York, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innocrin Pharmaceuticals Competitors (3)

One of Innocrin Pharmaceuticals’s 3 competitors is BiOrion, a Venture Capital-Backed company based in Groningen, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BiOrion Venture Capital-Backed Groningen, Netherlands
Innovimmune Biotherapeutics Accelerator/Incubator Backed New York, NY
Centrose Venture Capital-Backed Middleton, WI
You’re viewing 3 of 3 competitors. Get the full list »

Innocrin Pharmaceuticals Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 22

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Innocrin Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220370415-A1 Compositions for the treatment of brain tumors Pending 11-Oct-2018
US-20210154209-A1 Compositions for treatment of breast and prostate cancer Active 07-Dec-2017
US-11980626-B2 Compositions for treatment of breast and prostate cancer Active 07-Dec-2017
CA-2846117-A1 Metalloenzyme inhibitor compounds Inactive 30-Aug-2011
US-20140303157-A1 Metalloenzyme inhibitor compounds Active 30-Aug-2011 C07D277/24
To view Innocrin Pharmaceuticals’s complete patent history, request access »

Innocrin Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Innocrin Pharmaceuticals FAQs

  • When was Innocrin Pharmaceuticals founded?

    Innocrin Pharmaceuticals was founded in 2014.

  • Where is Innocrin Pharmaceuticals headquartered?

    Innocrin Pharmaceuticals is headquartered in Durham, NC.

  • What is the size of Innocrin Pharmaceuticals?

    Innocrin Pharmaceuticals has 10 total employees.

  • What industry is Innocrin Pharmaceuticals in?

    Innocrin Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Innocrin Pharmaceuticals a private or public company?

    Innocrin Pharmaceuticals is a Private company.

  • What is Innocrin Pharmaceuticals’s current revenue?

    The current revenue for Innocrin Pharmaceuticals is .

  • How much funding has Innocrin Pharmaceuticals raised over time?

    Innocrin Pharmaceuticals has raised $34.1M.

  • Who are Innocrin Pharmaceuticals’s competitors?

    BiOrion, Innovimmune Biotherapeutics, and Centrose are competitors of Innocrin Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »